Abstract

Background Acquired metallo-b-lactamases (MBLs) are emerging resistance determinants in clinically relevant Gram negative species. These enzymes confer broad spectrum b lactam resistance, including resistance to carbapenems. Their potential for rapid and wide dissemination makes them of great concern. Methods This study describes the molecular characterization of 15 Pseudomonas aeruginosa strains, isolated from endoscopic pus specimens, obtained from sinusitis cases. Susceptibility testing was performed by disk diffusion assay. The MIC of ceftazidime was determined by E test. Ceftazidime (CDM) - EDTA combined disc test was used to screen for class B b lactamase production. Plasmid DNA extraction was performed by alkali lysis method. The carriage of the MBL gene, blaVIM and IMP1 gene were screened by PCR. PCR products of 7 positive strains for MBL were sequenced and analysed using bioinformatics tools. Results Metallo-beta-lactamase was present in 9 strains. These results correlated with the presence of VIM1 gene by PCR. IMP1 gene was absent in all the 15 strains. Plasmid was present in 10 strains only. The nucleotide and deduced protein sequences were analyzed with the software available over the Internet. The nucleotide sequences reported in the study has been submitted to the Genbank and accession numbers were obtained (KF975367, KF975368, KF975369, KF975370, KF975371, KF975372, KF975373). A Phylogenetic tree was constructed and it consisted of 2 clades. Both the clades had evolved from the common ancestor VIM-28. Conclusion Direct detection of MBL genes may circumvent the problems of the phenotypic detection of carbapenemase producing microorganisms especially those exhibiting low carbapenem MICs.

Highlights

  • Acquired metallo-b-lactamases (MBLs) are emerging resistance determinants in clinically relevant Gram negative species. These enzymes confer broad spectrum b lactam resistance, including resistance to carbapenems. Their potential for rapid and wide dissemination makes them of great concern

  • Submit your manuscript to BioMed Central and take full advantage of:

Read more

Summary

Background

Acquired metallo-b-lactamases (MBLs) are emerging resistance determinants in clinically relevant Gram negative species. These enzymes confer broad spectrum b lactam resistance, including resistance to carbapenems. Their potential for rapid and wide dissemination makes them of great concern

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call